This live web event has ended. Thank you for attending.
The clinical use of multiplex PCR platforms, like the BioFire® FilmArray® Pneumonia (PN) Panel, in CAP patients dramatically increases the frequency of detection of potential viral and bacterial pathogens. The companion use of biomarkers, like VIDAS® BRAHMS PCT™, to measure serum procalcitonin levels helps adjudicate whether the detected potential pathogens are colonizing or invading. The combination of enhanced pathogen detection and PCT levels supports antibiotic stewardship activities.
This program is sponsored by BioFire Diagnostics, LLC.
By registering for this webinar, you agree your information will be shared with the sponsor.
No CME or MOC credits are available for this program.
Opinions expressed and resources shared may not have been reviewed by the ATS prior to distribution through ATS channels, or reflect official positions of the ATS, unless it is explicitly noted as a result of official ATS approval. References to specific commercial entities (companies) or products do not reflect review or endorsement by the ATS unless it is explicitly noted as a result of official ATS approval.